Channel:  SeroNet

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

57 Articles

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo
Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., Lee, R. E., Mascenik, T. M., Edwards, C. E., Tse, L. V., Boucher, R. C., Randell, S. H., Suzuki, T., Gralinski, L. E., Kawaoka, Y., Baric, R. S.
10.1101/2020.09.28.317685 — Posted: 2020-09-29
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19
Rappazzo, C. G., Tse, L. V., Kaku, C. I., Wrapp, D., Sakharkar, M., Huang, D., Deveau, L. M., Yockachonis, T. J., Herbert, A. S., Battles, M. B., O'Brien, C. M., Brown, M. E., Geoghegan, J. C., Belk, J., Peng, L., Yang, L., Scobey, T. D., Burton, D. R., Nemazee, D., Dye, J. M., Voss, J. E., Gunn, B. M., McLellan, J. S., Baric, R. S., Gralinski, L. E., Walker, L. M.
10.1101/2020.11.17.385500 — Posted: 2020-11-17
Physiology of cardiomyocyte injury in COVID-19
Siddiq, M. M., Chan, A. T., Miorin, L., Yadaw, A. S., Beaumont, K. G., Kehrer, T., White, K. M., Cupic, A., Tolentino, R. E., Hu, B., Stern, A. D., Tavassoly, I., Hansen, J., Martinez, P., Dubois, N., Schaniel, C., Iyengar-Kapuganti, R., Kukar, N., Giustino, G., Sud, K., Nirenberg, S., Kovatch, P., Goldfarb, J., Croft, L., McLaughlin, M. A., Argulian, E., Lerakis, S., Narula, J., Garcia-Sastre, A. M., Iyengar, R.
10.1101/2020.11.10.20229294 — Posted: 2020-11-16
Durable SARS-CoV-2 B cell immunity after mild or severe disease
Ogega, C. O., Skinner, N. E., Blair, P. W., Park, H.-S., Littlefield, K., Ganesan, A., Ladiwala, P., Antar, A. A., Ray, S. C., Betenbaugh, M. J., Pekosz, A., Klein, S., Manabe, Y. C., Cox, A. L., Bailey, J. R.
10.1101/2020.10.28.20220996 — Posted: 2020-10-30
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Bubar, K. M., Reinholt, K., Kissler, S. M., Lipsitch, M., Cobey, S., Grad, Y., Larremore, D. B.
10.1101/2020.09.08.20190629 — Posted: 2021-01-08
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., Nakao, C., Rayaprolu, V., Rawlings, S. A., Peters, B., Krammer, F., Simon, V., Saphire, E. O., Smith, D., Weiskopf, D., Sette, A., Crotty, S.
10.1101/2020.11.15.383323 — Posted: 2020-12-18
Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers
da Silva Antunes, R., Pallikkuth, S., Williams, E., Esther, Y. D., Mateus, J., Quiambao, L., Wang, E., Rawlings, S. A., Stadlbauer, D., Jiang, K., Amanat, F., Arnold, D., Andrews, D., Fuego, I., Dan, J. M., Grifoni, A., Weiskopf, D., Krammer, F., Crotty, S., Hoffer, M. E., Pahwa, S. G., Sette, A.
10.1101/2021.01.12.21249683 — Posted: 2021-01-15
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
Reuschl, A.-K., Thorne, L., Zuliani Alvarez, L., Bouhaddou, M., Obernier, K., Hiatt, J., Soucheray, M., Turner, J., Fabius, J., Nguyen, G. T., Swaney, D., Rosales, R., White, K. M., Aviles, P., Kirby, I. T., Melnyk, J. E., Shi, Y., Zhang, Z., Shokat, K., Garcia-Sastre, A., Jolly, C., Towers, G. J., Krogan, N. J.
10.1101/2021.01.24.427991 — Posted: 2021-02-04
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
Rathnasinghe, R., Jangra, S., Cupic, A., Martinez-Romero, C., Mulder, L. C. F., Kehrer, T., Yildiz, S., Choi, A., Mena, I., De Vrieze, J., Aslam, S., Stadlbauer, D., Meekins, D. A., McDowell, C. D., Balaraman, V., Richt, J. A., De Geest, B. G., Miorin, L., Personalized Virology Initiative, , Krammer, F., Simon, V., Garcia-Sastre, A., Schotsaert, M.
10.1101/2021.01.19.21249592 — Posted: 2021-01-20
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
Gorman, M. J., Patel, N., Guebre-Xabier, M., Zhu, A., Atyeo, C., Pullen, K., Loos, C., Goez-Gazi, Y., Carrion, R., Tian, J.-H., Yuan, D., Bowman, K., Zhou, B., Maciejewski, S., McGrath, M., Logue, J., Frieman, M., Montefiori, D., Mann, C., Schendel, S., Amanat, F., Krammer, F., Saphire, E. O., Lauffenburger, D. A., Greene, A. M., Portnoff, A. D., Massare, M. J., Ellingsworth, L., Glenn, G., Smith, G., Alter, G.
10.1101/2021.02.05.429759 — Posted: 2021-02-05

RSS  Channel RSS